• Genomic Analysis for the evaluation of the risk associated to disorders and pathologic aging
• Customized preventive treatments to extend life and improve its quality
• Proprietary and third party research on products and applications for preventing, slowing or inverting pathologic aging processes

Genomic analysis on SNPs (Single Nucleotide Polimorphisms) panel, related to most common degenerative pathologic risks.

These panels are selected by Genalta’s Scientific Board on the basis of the most advanced scientific research.

SNPs are selected taking also into consideration associated nutritional treatments (nutrigenomics).

The tissue sample requested for genomic analysis is taken by a non-invasive and painless technique consisting in rubbing the inside of the cheek with a pad. The genomic sequence is identified and then SNPs are highlighted.

On the basis of the results of the genomic analysis, Genalta’s medical team suggests customized diagnostic exams based on "traditional medicine" techniques.

At the end of the exam cycle, Genalta’s medical team suggests a customized preventive treatment.